Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B5c7a76b314da7c4c14c47066d638a5c4> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B5c7a76b314da7c4c14c47066d638a5c4 NCIT_P378 "NCI" @default.
- B5c7a76b314da7c4c14c47066d638a5c4 type Axiom @default.
- B5c7a76b314da7c4c14c47066d638a5c4 annotatedProperty IAO_0000115 @default.
- B5c7a76b314da7c4c14c47066d638a5c4 annotatedSource NCIT_C200128 @default.
- B5c7a76b314da7c4c14c47066d638a5c4 annotatedTarget "A radioconjugate consisting of an Evans blue (EB) modified fibroblast activation protein inhibitor (FAPi), conjugated with the bifunctional, macrocyclic chelating agent tetra-azacyclododecane tetraacetic acid (DOTA) and radiolabeled with the beta-emitting radioisotope lutetium Lu 177, with potential antineoplastic activity. Upon administration of lutetium Lu 177 LNC1004, the FAPi moiety targets and binds to FAP-expressing cancer-associated fibroblasts (CAFs). Upon binding and internalization, the radioconjugate specifically delivers a cytotoxic dose of beta radiation to FAP-expressing CAFs. FAP, a cell surface protein, is overexpressed on CAFs in the tumor microenvironment (TME)." @default.